FLACU

Frazier Lifesciences Acquisition Corp., established in 2020 and headquartered in Seattle, Washington, currently conducts no substantial business activities. Its core objective is to complete a strategic transaction, such as a merger, acquisition, or other business combination, with one or more enterprises within the biotechnology industry.